Screener
Theravance Biopharma TBPH Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OtherPrepaidExpenseCurrent.
The source filing: Theravance Biopharma’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 8:00 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-093773
FAQ
- What is Theravance Biopharma's prepaid & other current?
- Theravance Biopharma (TBPH) reported prepaid & other current of $8.62M in Q2 2026.
- How has Theravance Biopharma's prepaid & other current changed year-over-year?
- Theravance Biopharma's prepaid & other current increased by 54.8% year-over-year, from $5.57M to $8.62M.
- What is the long-term trend for Theravance Biopharma's prepaid & other current?
- Over 5 years (2020 to 2025), Theravance Biopharma's prepaid & other current has grown at a -6.1% compound annual growth rate (CAGR), from $10.36M to $7.56M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Theravance Biopharma's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude